Wegovy Archives - TPR: The Public's Radio

Photo Illustration of the new Wegovy 1.5 mg and 4 mg semaglutide tablets with injectable prescription weight loss pens on a white background. Its a prescription medicine used with a reduced calorie diet and physical activity. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images)

NPR

A new Medicare option for weight loss drugs is coming: Here’s what to know

by Jackie Fortiér 1 day agoMay 6, 2026

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here’s how it will work.

Meghan Lena was devastated when she lost coverage for her obesity medication.

NPR

Restrictions on obesity drug coverage force patients to pivot

by Sydney Lupkin April 22, 2026April 22, 2026

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.

A box labeled Wegovy sits atop a box of Zepbound on a table.

NPR

Quit a GLP-1? Plan to start again? It’s not recommended, but plenty of people do it

by Yuki Noguchi April 15, 2026April 15, 2026

A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again. Research hasn’t yet shown the health impacts of cycling on and off the drugs.

A close up photo shows a bit of chicken, rice, carrot and edamame on a fork.

NPR

What does a ‘GLP-1 Friendly’ diet look like? We asked nutritionists

by Yuki Noguchi March 23, 2026March 23, 2026

Big food companies are starting to market to people on the powerful new obesity meds with labels that say “GLP-1 Friendly.” Nutritionists help us decode that message.

A woman in pajamas is shown holding an injection pen in front of her torso.

NPR

GLP-1 drugs don’t work for everyone. But personalized obesity care in the future might

by Yuki Noguchi January 27, 2026January 27, 2026

As doctors learn why GLP-1s don’t work for about 50% of people, they are also learning more about the complex drivers of obesity. They foresee a future of personalized obesity medicine similar to the way cancer is treated now.

A pill form of Wegovy, the popular obesity drug previously available only by injection, is seen in a plastic tray.

NPR

Wegovy obesity pill now available at pharmacies

by Sydney Lupkin January 5, 2026January 5, 2026

Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.

A box of Ozempic at a pharmacy in Los Angeles on Aug. 6, 2025.

NPR

Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy

by Sydney Lupkin November 26, 2025November 26, 2025

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.

White round pills in orange bottle on blue background banner close up with copy space

NPR

5 things to know about the new obesity pills that are on the way

by Sydney Lupkin November 25, 2025November 25, 2025

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.